Skip to content

Selecting suitable biological indicators for H2O2 bio-decontamination

Mai 2026

Authors:

Martin Novák

SKAN

Veronika Zysk

SKAN

Sarah Peter

SKAN

Scientific paper

PDF

Download here

About the paper

The paper highlights the importance of carefully selecting and qualifying biological indicators for H₂O₂ bio-decontamination processes. Because commercially available BIs can vary considerably in quality and resistance, lot-to-lot variability may have a direct impact on process validation results. The authors therefore emphasize the need for a robust, fit-for-purpose BI quality control strategy that goes beyond the requirements currently addressed in regulatory guidance. Clearly defined BI quality attributes and suitability acceptance criteria can help ensure more reliable, reproducible, and defensible validation outcomes.

Why the topic matters

Biological indicators are a key tool for demonstrating the effectiveness of H₂O₂ bio-decontamination processes. However, commercially available BIs can vary significantly in quality and lot-to-lot consistency. Since current regulatory guidance does not sufficiently address BI resistance characteristics, selecting and qualifying suitable BIs is critical to achieving reliable, reproducible, and defensible validation results.

Get free access to our scientific paper!

*required

About the authors:

  • Martin Novák (Technology Lead at SKAN)

    Martin Novák has more than 10 years of experience in pharmaceutical Ru0026amp;D, with a background in drug synthesis and manufacturing. As Technology Lead at SKAN, he plays a key role in advancing decontamination strategies and isolator technology and contributes to international standardization as well as industry initiatives within PDA and ISPE.

  • Veronika Zysk (Administrative Laboratory Specialist at SKAN)

    Veronika Zysk studied hygiene technology and graduated with a degree in hygiene engineering Dipl. Ing. (FH). For more than 25 years, she has been working with BI intended for Isolators with H2O2 bio-decontamination, in the frame of cycle development and microbiological qualification, Quality Control Testing and BI manufacturing.

  • Sara Richard (Peter) (Head Quality Control u0026 Lab Operations at SKAN)

    Sarah Richard (Peter) is a Quality Control (QC) Manager with over eight years of experience in Biological Indicator (BI) QC testing and a strong background in pharmaceutical sterility testing. As QC Head at SKAN AG, she oversees BI testing processes and defines quality standards to ensure the reliability and performance of BIs.

Back to top